Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pediatric Crohn's disease × Methotrexate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 157 Leukemia 114 Lymphoma 80 Leukemia, Myeloid, Acute 72 Myelodysplastic Syndromes 57 Burkitt Lymphoma 52 Lymphoma, Non-Hodgkin 45 Lymphoma, Large B-Cell, Diffuse 36 Lymphoma, Mantle-Cell 34 Graft vs Host Disease 34 Leukemia, Myeloid, Accelerated Phase 32 Leukemia, Lymphocytic, Chronic, B-Cell 32 Hodgkin Disease 32 Breast Neoplasms 29 Blast Crisis 29 Multiple Myeloma 28 Lymphoma, Follicular 28 Recurrence 27 Leukemia, Myeloid, Chronic-Phase 27 Congenital Abnormalities 26 Myeloproliferative Disorders 25 Leukemia, Myelomonocytic, Chronic 25 Lymphoma, Large-Cell, Immunoblastic 22 Primary Myelofibrosis 21 Lymphoma, B-Cell, Marginal Zone 21 Osteosarcoma 19 Neoplasms, Plasma Cell 19 Hematologic Neoplasms 19 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 18 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 17

Interventions

Sugars 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02772965 2023-04-12

COMBINE

University of North Carolina, Chapel Hill

Phase 3 Completed

306 enrolled 16 charts

Pediatric Crohn's disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡